Charles Schwab Investment Management Inc Cin Cor Pharma, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$10.75 - $29.84 $186,297 - $517,127	17,330 Added 12.54%	155,534 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $933,767 - $1.83 Million	46,923 Added 51.41%	138,204 $4.54 Million
Q2 2022 Aug 15, 2022	BUY	$13.67 - $25.74 $32,725 - $61,621	2,394 Added 2.69%	91,281 $1.72 Million
Q1 2022 May 13, 2022	BUY	$14.13 - $28.49 $1.26 Million - $2.53 Million	88,887 New	88,887 $1.56 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.